Intervention
Esophagogastroduodenoscopy
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownTrans-nasal Endoscopy for Bariatric PatientsNCT06200961 · 2026-04-20
RECRUITINGImpact of Neuropathy on the Risk of Semaglutide-Induced Gastric RetentionNCT07156591 · 2025-09-15
NOT_YET_RECRUITING24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)NCT05634746 · 2022-12-29
COMPLETEDEfficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)NCT04281108 · 2020-01-30
COMPLETEDEGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.NCT04191369 · 2019-11-01
UNKNOWNCommon conditions
Leading sponsors
Trial status mix
COMPLETED2
NOT_YET_RECRUITING1
RECRUITING1
UNKNOWN1
Phase mix
NA2
PHASE32
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.